| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.069 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |